Carla J. Kinslow, Ph.D.
About
Dr. Carla J. Kinslow is a physician specializing in radiation oncology, with research and clinical work focused on cancers of the brain and breast, including gliomas and breast implant-associated anaplastic large cell lymphoma. Her work spans both treatment and outcomes research, with particular attention to disparities in cancer diagnosis and survival among adolescents, young adults, and patients from underrepresented racial and ethnic groups.
Dr. Kinslow has published across more than 60 peer-reviewed articles appearing in journals including the Journal of the National Cancer Institute, JAMA Network Open, the International Journal of Radiation Oncology, Biology, Physics, and Nature Mental Health. Her published research addresses topics such as adaptive radiation therapy planning for high-grade glioma, targeted drug delivery in diffuse midline glioma, the incidence and demographics of breast implant-associated lymphoma following mastectomy reconstruction, future treatment directions for low-grade gliomas, and psilocybin-assisted psychotherapy for psychiatric symptoms in cancer patients. This range of work reflects engagement with both technical treatment questions and broader questions of patient outcomes and equity.
Publications
- Incidence of breast implant-associated anaplastic large cell lymphoma.
- Anaplastic Large Cell Lymphoma of the Breast by Race and Ethnicity.
- Lymphomas of the Breast After Postmastectomy Implant-Based Breast Reconstruction.
- Timing of Planning Magnetic Resonance Imaging and Patient Selection for Adaptive Radiation Therapy in Newly Diagnosed High-Grade Glioma.
- Future Directions in the Treatment of Low-Grade Gliomas.
- Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.
- Targeted delivery of napabucasin with radiotherapy improves outcomes in diffuse midline glioma.
- Racial Disparities in Cancer Stage at Diagnosis and Survival for Adolescents and Young Adults.
- Comparison of Hybribio-H13 and Hybrid Capture® 2 human papillomavirus tests for detection of CIN2+ and CIN3.
- Stable isotope-resolved metabolomics analyses of metabolic phenotypes reveal variable glutamine metabolism in different patient-derived models of non-small cell lung cancer from a single patient.
Request CV and rates
Tell us about your case and we'll connect you with Carla J. Kinslow, Ph.D. within two business days.
Other Oncology experts
Verified specialists available for your case.
